The Critical Role of Complement Alternative Pathway Regulator Factor H in Allergen-Induced Airway Hyperresponsiveness and Inflammation
- 15 January 2012
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 188 (2) , 661-667
Abstract
Activation of the alternative pathway of complement plays a critical role in the development of allergen-induced airway hyperresponsiveness (AHR) and inflammation in mice. Endogenous factor H, a potent inhibitor of the alternative pathway, is increased in the airways of sensitized and challenged mice, but its role in regulating inflammation or AHR has been unknown. We found that blocking the tissue-binding function of factor H with a competitive antagonist increased complement activation and tissue inflammation after allergen challenge of sensitized mice. Conversely, administration of a fusion protein that contains the iC3b/C3d binding region of complement receptor 2 linked to the inhibitory region of factor H, a molecule directly targeting complement-activating surfaces, protected mice in both primary and secondary challenge models of AHR and lung inflammation. Thus, although endogenous factor H does play a role in limiting the development of AHR, strategies to deliver the complement-regulatory region of factor H specifically to the site of inflammation provide greater protection than that afforded by endogenous regulators. Such an agent may be an effective therapy for the treatment of asthma.Keywords
This publication has 37 references indexed in Scilit:
- Correlation of plasma complement split product levels with allergic respiratory disease activity and relation to allergen immunotherapyAnnals of Allergy, Asthma & Immunology, 2010
- A Protective Role for C5a in the Development of Allergic Asthma Associated with Altered Levels of B7-H1 and B7-DC on Plasmacytoid Dendritic CellsThe Journal of Immunology, 2009
- Translational Mini-Review Series on Complement Factor H: Structural and functional correlations for factor HClinical and Experimental Immunology, 2007
- Translational Mini-Review Series on Complement Factor H: Genetics and disease associations of human complement factor HClinical and Experimental Immunology, 2007
- Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic AutoantibodiesThe American Journal of Pathology, 2007
- Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammationProceedings of the National Academy of Sciences, 2006
- Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthmaJournal of Allergy and Clinical Immunology, 2005
- Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway responseJournal of Clinical Investigation, 2005
- Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthmaHuman Genetics, 2004
- Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor HNature Genetics, 2002